I now have enough comprehensive material to write a detailed evaluation report. Let me compile everything:---
Mechanical Ventilator: A Detailed Evaluation Report
1. Introduction and Definition
A mechanical ventilator is a life-sustaining medical device that provides partial or full respiratory support for patients who cannot adequately maintain gas exchange on their own. Its primary functions are to maintain adequate oxygenation and CO2 elimination, rest the respiratory muscles, reduce the oxygen cost of breathing, and minimize iatrogenic consequences during support.
Modern ventilation strategies have shifted focus from simply normalizing blood gases to protecting lung parenchyma and respiratory muscles from injury - a concept that defines the entire philosophy of contemporary ventilator management.
- Goldman-Cecil Medicine, p. 1059
2. Historical Context
Mechanical ventilation evolved from simple life-support measures to a complex, protocol-driven discipline. Early devices used negative-pressure ventilation ("iron lungs"); modern positive-pressure ventilators were refined after the polio epidemics of the 1950s. Subsequent decades introduced volume-controlled ventilation, PEEP, and microprocessor-driven feedback systems. The landmark ARDSNet ARMA trial (2000) established low-tidal-volume (lung-protective) ventilation as standard of care - a paradigm shift that reduced ARDS mortality by approximately 22%.
- Fishman's Pulmonary Diseases, Reference section
- Miller's Anesthesia, 10e
3. Indications for Mechanical Ventilation
3.1 General Indications
Mechanical ventilation is indicated when a patient cannot maintain adequate spontaneous respiration. The main clinical indications are:
| Category | Examples |
|---|
| Airway compromise | Upper airway obstruction, angioedema, epiglottitis |
| Airway protection | Obtunded/unconscious patients, GCS ≤8, aspiration risk |
| Hypoventilation | Neuromuscular disease (GBS, MG, ALS), overdose, chest wall injury |
| Refractory hypoxemia | ARDS, severe pneumonia, pulmonary edema (PaO2/FiO2 <200) |
| Cardiac/respiratory arrest | Immediate life support |
| Failure of NIV | Worsening acidosis, declining mental status |
| Intraoperative support | General anesthesia requiring paralysis |
For COPD exacerbations, the decision is not dictated by any particular ABG value but is made on clinical grounds. If the patient is alert and cooperative, mechanical ventilation is often not necessary - noninvasive positive pressure ventilation (NIPPV) is first-line.
- Goldman-Cecil Medicine, p. 1342-1343
For asthma requiring intubation, specific triggers include coma, cardiac or respiratory arrest, paradoxical breathing, refractory hypoxemia, and failure of NIV. ABG results alone do not dictate the need for intubation; overall clinical assessment is superior.
- Rosen's Emergency Medicine, p. 2071
4. Types of Mechanical Ventilation
4.1 Invasive Mechanical Ventilation (IMV)
Delivered through an endotracheal tube (ETT) or tracheostomy. Used for patients requiring full respiratory support, airway protection, or when NIV has failed.
4.2 Noninvasive Ventilation (NIV / NIPPV)
Delivered via a tight-fitting face mask. Preferred in COPD exacerbation, acute cardiogenic pulmonary edema, and in appropriate patients without contraindications (markedly reduced mental status, hypotension, inability to tolerate mask).
4.3 Positive-Pressure vs. Negative-Pressure
Modern ventilators universally use positive-pressure ventilation - gas is pushed into the lungs. Negative-pressure ventilation (tank respirators) is rarely used today except in specific neuromuscular conditions.
5. Modes of Mechanical Ventilation
Ventilator modes define how breaths are triggered, limited, and cycled. Understanding each mode is central to ventilator evaluation.
5.1 Continuous Mandatory Ventilation (CMV) / Assist-Control (AC)
CMV provides preset mandatory machine-delivered breaths at a fixed rate using either volume control (VCV) or pressure control (PCV). In pure CMV, the ventilator provides breaths without patient triggering.
- Used in heavily sedated or paralyzed patients
- Risk: diaphragmatic inactivity leading to atrophy and contractility dysfunction
- In Assist-Control (AC): if the patient triggers a breath above the set rate, the full preset volume or pressure is delivered for each triggered breath
5.2 Synchronized Intermittent Mandatory Ventilation (SIMV)
The ventilator delivers a set number of mandatory breaths synchronized with the patient's effort; additional patient-initiated breaths receive no mandatory support (though pressure support can be added).
- Allows patient to exercise respiratory muscles
- Often used during weaning (rate progressively reduced)
- In unassisted SIMV, spontaneous breaths may impose high work of breathing
5.3 Pressure Support Ventilation (PSV)
A patient-triggered, pressure-limited, flow-cycled mode. Each patient-initiated breath receives a fixed pressure boost. No mandatory rate is set.
- Primarily used during weaning and for spontaneous breathing trials
- The patient controls respiratory rate and tidal volume
- Augments patient effort; reduces work of breathing
5.4 Volume-Controlled Ventilation (VCV)
Breaths are volume-cycled, time-triggered, and flow-limited. A fixed tidal volume is delivered regardless of airway resistance or compliance changes. Airway pressure varies with changing lung mechanics.
- Advantage: guaranteed minute ventilation
- Risk: high peak pressures if compliance decreases
5.5 Pressure-Controlled Ventilation (PCV)
Breaths are time-cycled, time-triggered, and pressure-limited. A fixed inspiratory pressure is applied; tidal volume varies with compliance and resistance.
- More physiologic flow pattern
- Tidal volume must be monitored because it can fluctuate
- Between VCV and PCV, no significant clinical outcome difference has been demonstrated in ARDS as long as low tidal volumes are maintained
5.6 Airway Pressure Release Ventilation (APRV)
Holds a high constant inspiratory pressure (P-high) with brief periodic releases to a lower pressure (P-low), with spontaneous respiratory activity superimposed.
- Proposed benefit: increased aeration, reduced alveolar collapse cycling
- Some observational data suggest early use in trauma may reduce ARDS incidence
- Remains controversial - not universally adopted due to unproven clinical benefits and associated risks
5.7 High-Frequency Oscillatory Ventilation (HFOV)
Delivers very low tidal volumes (<100 mL) at very high rates (hundreds of breaths/min) using a special oscillator pump. Gas transfer occurs via "pendelluft" effect and enhanced diffusion rather than bulk flow.
-
Initial enthusiasm but subsequent RCTs showed no mortality benefit and possible harm in adults with ARDS
-
Largely abandoned for routine adult ARDS management
-
Still used in neonatal/pediatric populations
-
Current Surgical Therapy 14e, p. 2847-2870
-
Mulholland and Greenfield's Surgery, p. 187-205
-
Miller's Anesthesia 10e, p. 548-560
6. Initial Ventilator Settings
Selecting appropriate initial settings is the first critical evaluation step when placing a patient on mechanical ventilation.
| Parameter | Recommended Initial Setting |
|---|
| FiO2 | 1.0 (100%) initially, wean to <0.4 to prevent O2 toxicity |
| Tidal Volume (VT) | 6-8 mL/kg ideal body weight (IBW) |
| Respiratory Rate (RR) | 12-16 breaths/min |
| PEEP | Start at 5 cm H2O; titrate upward to improve oxygenation |
| Inspiratory Flow Rate | 60 L/min (higher in asthma to allow expiratory time) |
| ETCO2/PaCO2 target | ~40 mm Hg (not the traditional 30-35 mm Hg) |
-
Oxygenation goal: PaO2 >60 mm Hg, SpO2 >90%
-
After initial ABG/SpO2 check, wean FiO2 to maintain SpO2 >90% or PaO2 >60 mm Hg with FiO2 <0.4
-
Mulholland and Greenfield's Surgery, p. 189
-
Current Surgical Therapy 14e, p. 2725-2726
7. Physiological Principles of Gas Exchange During Mechanical Ventilation
7.1 Oxygenation
Three main strategies improve oxygenation:
- Increase FiO2 - raises available oxygen for hemoglobin transport; high FiO2 (>50%) risks oxygen toxicity and absorptive atelectasis
- Increase mean airway pressure - via higher PEEP, increased driving pressure, or adjusted I:E ratio; improves V/Q matching and alveolar recruitment
- Recruitment maneuvers - transient pressure increases to open collapsed alveoli; must be followed by adequate PEEP to prevent recollapse; risk of barotrauma and transient decreased cardiac output
7.2 Ventilation (CO2 Elimination)
Alveolar ventilation = Minute ventilation - Dead space ventilation
- Minute ventilation = RR × VT
- To increase CO2 clearance: increase RR or VT
- In obstructive disease (asthma, COPD): prolonging expiratory time is paramount - use lower RR and higher inspiratory flow rates to prevent auto-PEEP
7.3 V/Q Mismatch
The most common cause of hypoxemia in lung disease. Mechanical ventilation attempts to improve V/Q mismatch and reduce shunt fraction. Unlike hypoxemia from V/Q mismatch, shunt-based hypoxemia is not corrected by increasing FiO2 alone (shunted blood is never exposed to higher alveolar PO2).
- Murray & Nadel's Respiratory Medicine
- Goldman-Cecil Medicine, p. 1605
8. Monitoring and Evaluation During Mechanical Ventilation
This is the core of ventilator evaluation - continuous assessment of patient-ventilator interaction and adequacy of support.
8.1 Airway Pressure Monitoring
Peak Inspiratory Pressure (PIP)
- Reflects resistance + compliance
- Sudden increase: bronchospasm, mucus plug, pneumothorax, kinked ETT
- Sudden decrease: airway leak or circuit disconnection
Plateau Pressure (Pplat)
- Measured during inspiratory hold; reflects alveolar pressure (static compliance)
- Target: <30 cm H2O (lung-protective threshold)
- Lower plateau pressures (<16 cm H2O) associated with lowest postoperative pulmonary complication rates
- AARC 2024 CPG: strong recommendation to assess Pplat to ensure lung-protective settings
Driving Pressure
- = Pplat - PEEP
- Direct correlation between elevated driving pressure and postoperative pulmonary complications (PPCs)
- Target: <15 cm H2O in ARDS
8.2 Waveform Analysis (Scalars and Loops)
Flow-Time Scalar
- Identifies auto-PEEP (intrinsic PEEP): expiratory flow does not return to zero before the next breath
- Consequence: air trapping, barotrauma, hemodynamic instability
- Management: decrease VT, RR, or inspiratory time; increase flow rate
Pressure-Time Scalar
- Negative deflection at breath initiation confirms spontaneous breathing
- Allows calculation of dynamic compliance
- High peak pressures = bronchospasm or kinked tube; sharp drop = air leak
Volume-Time Scalar
- Identifies circuit leaks (volume curve does not return to baseline)
Pressure-Volume Loop
- Identifies overdistension (upper inflection point - "bird beak" shape)
- Identifies opening pressure / lower inflection point for PEEP optimization
Flow-Volume Loop
-
Identifies obstructive pattern (scooped-out expiratory limb)
-
Mulholland and Greenfield's Surgery, p. 192-207
8.3 Arterial Blood Gas (ABG) Analysis
ABG remains the gold standard for evaluating ventilator adequacy:
| Parameter | Significance |
|---|
| PaO2 | Oxygenation (target >60 mm Hg; >70-100 mm Hg in conservative protocols) |
| PaCO2 | Ventilation adequacy (target ~35-45 mm Hg; permissive hypercapnia acceptable >45) |
| pH | Acid-base status; target >7.25 for weaning consideration |
| P/F ratio | PaO2/FiO2; ARDS severity (mild 201-300, moderate 101-200, severe ≤100) |
| SpO2 | Continuous pulse oximetry surrogate; target 94-98% in most patients |
A conservative oxygen strategy (PaO2 target 70-100 mm Hg, SpO2 94-98%) is at least as good as liberal oxygenation therapy. Targeting SpO2 90% or PaO2 55-75 mm Hg is not beneficial.
- Goldman-Cecil Medicine, p. 1607
8.4 End-Tidal CO2 (ETCO2) Monitoring
- Continuous capnography provides real-time ventilation adequacy
- Maintain ETCO2 ~40 mm Hg (improves organ perfusion)
- In asthma: ETCO2 trending upward signals impending respiratory failure
- PaCO2 >100 mm Hg should be avoided (risk of increased intracranial pressure via cerebral vasodilation)
8.5 Respiratory Mechanics Assessment
Static Compliance
- C = VT / (Pplat - PEEP)
- Normal: 60-100 mL/cm H2O
- Reduced in ARDS, pulmonary edema, pneumothorax, massive atelectasis
Auto-PEEP Detection
- Apply expiratory hold and read displayed pressure
- If >5 cm H2O: reduce RR, prolong expiratory time, reduce VT, increase inspiratory flow rate
9. Lung-Protective Ventilation Strategy
The cornerstone of modern ICU ventilation, particularly in ARDS:
| Element | Target |
|---|
| Tidal Volume | 4-8 mL/kg IBW |
| Plateau Pressure | <30 cm H2O |
| Driving Pressure | <15 cm H2O |
| PEEP | Adequate to prevent derecruitment |
| SpO2 | 88-95% (permissive hypoxia acceptable) |
| pH | >7.20-7.25 (permissive hypercapnia acceptable) |
AARC 2024 Clinical Practice Guideline (strong recommendations):
- Assess Pplat to ensure lung-protective settings
- Assess VT to ensure 4-8 mL/kg predicted body weight
- Assessment should be patient-centric, not ventilator-centric
10. Ventilator-Induced Lung Injury (VILI)
VILI is a major hazard of mechanical ventilation and forms a critical domain of ventilator evaluation. Four primary mechanisms:
10.1 Barotrauma
Physical injury from excessive airway pressure - pneumothorax, pneumomediastinum, subcutaneous emphysema.
- Prevention: limit Pplat to <30 cm H2O
10.2 Volutrauma
Diffuse alveolar injury from overdistension - damage to the alveolar epithelium from excessive tidal volumes regardless of pressure.
- Prevention: VT 6-8 mL/kg IBW; avoid VT <6 or >10 mL/kg
10.3 Atelectrauma (Cyclic Shear Stress)
Repeated opening and closing of collapsed alveoli generates shear forces and epithelial injury.
- Prevention: adequate PEEP to maintain alveolar recruitment; recruitment maneuvers followed by PEEP
10.4 Biotrauma
Release of pro-inflammatory mediators (cytokines, chemokines) from injured lung parenchyma into the systemic circulation, potentially causing multi-organ dysfunction.
- The most insidious form of VILI; drives ICU mortality via systemic inflammation
The pressure-volume curve illustrates the "safe window" - the target range between the zone of overdistension (high Pplat/VT) and the zone of derecruitment/atelectasis (insufficient PEEP).
- Current Surgical Therapy 14e, p. 2842-2844
- Murray & Nadel's Respiratory Medicine, Block 32
- Miller's Anesthesia 10e, p. 550-555
11. Complications of Mechanical Ventilation
11.1 Hemodynamic Compromise
- Positive intrathoracic pressure reduces venous return and cardiac output
- Particularly dangerous in volume-depleted or high-PEEP patients
- Management: volume resuscitation, reduce PEEP, slow ventilator rate
In asthmatic patients, hypotension is almost universally secondary to increased intrathoracic pressure with decreased venous return. Slowing ventilator rate or briefly disconnecting the patient allows complete exhalation and pressure relief.
- Rosen's Emergency Medicine, p. 2079
11.2 Ventilator-Associated Pneumonia (VAP)
- Incidence increases with duration of intubation
- Prevention bundle: head-of-bed elevation 30-45°, oral decontamination, sedation minimization, subglottic suctioning, early enteral nutrition
- Choice of airway humidification (heated humidifiers vs. heat-moisture exchangers) shows no significant difference in VAP incidence (2024 AARC CPG, 34 trials, n=2,828)
11.3 Oxygen Toxicity
- Prolonged high FiO2 (>50-60%) produces reactive oxygen species causing further lung injury
- Target FiO2 <0.4 once oxygenation confirmed
11.4 Respiratory Muscle Wasting
- Prolonged controlled ventilation causes diaphragmatic atrophy within 18-69 hours
- Strategy: maintain some spontaneous breathing activity where safe; early spontaneous breathing trials
11.5 Auto-PEEP / Breath Stacking
- Particularly dangerous in obstructive lung disease
- Leads to progressive hyperinflation, barotrauma, and cardiovascular collapse
11.6 Endotracheal Tube Complications
- Malposition (right mainstem intubation), cuff overinflation, tracheomalacia
- Evaluate with chest X-ray; cuff pressure target 20-30 cm H2O
12. Special Ventilator Strategies by Disease
12.1 ARDS
- Volume-controlled or pressure-controlled: no difference in outcomes when VT is kept low
- VT 4-6 mL/kg IBW, PEEP titrated to P/F ratio
- ARDS severity categorized by P/F ratio (Berlin definition, with ≥5 cm H2O PEEP):
- Mild: P/F 201-300
- Moderate: P/F 101-200
- Severe: P/F ≤100
12.2 Obstructive Lung Disease (COPD, Asthma)
- Low rate (≤10 breaths/min in asthma), high inspiratory flow (>60 L/min)
- Short I:E ratio to maximize expiratory time
- Low VT (6-8 mL/kg) to minimize auto-PEEP
- Permissive hypercapnia: target pH >7.25, avoid PaCO2 >100 mm Hg
12.3 Neuromuscular Disease
- May need full ventilatory support (full CMV)
- When disease resolves, can wean rapidly
12.4 Post-Operative
- Lung-protective ventilation (VT 6-8 mL/kg, PEEP 5-10 cm H2O) reduces postoperative pulmonary complications
- Avoid supraphysiologic VT ≥10 mL/kg without open-lung techniques
- ETCO2 target ~40 mm Hg for optimal perfusion
13. Weaning and Liberation from Mechanical Ventilation
Liberation from mechanical ventilation (sometimes called weaning) is the process of progressively withdrawing ventilator support. This is a two-phase process: (1) readiness testing and (2) weaning/liberation itself.
13.1 Prerequisites for Weaning ("Readiness Criteria")
Before initiating a weaning trial, all of the following should be addressed:
-
The underlying condition requiring MV has been reversed or controlled
-
Hemodynamically stable (not actively titrating vasopressors; HR <130, MAP >60 mmHg)
-
Adequate oxygenation: SpO2/PaO2 satisfactory on FiO2 ≤0.5, PEEP ≤8 cm H2O
-
pH >7.32 (some protocols accept >7.25)
-
RR 8-35 breaths/min
-
Hgb >7 g/dL
-
Spontaneous breathing effort present; patient not paralyzed
-
Adequate neurological status: arousable (RASS > -2), able to follow commands, intact cough/airway reflexes
-
Resolution of bronchospasm, cardiac failure, infection, metabolic derangements, anemia, altered mental status, sleep deprivation
-
Absence of active myocardial ischemia
-
Morgan and Mikhail's Clinical Anesthesiology 7e, p. 4267-4268
-
STICU Weaning Protocol (UTHealth Houston, last reviewed 07/2024)
13.2 Mechanical Weaning Indices (Evaluation Parameters)
| Criterion | Threshold for Successful Weaning |
|---|
| Maximum Inspiratory Pressure (MIP/NIF) | More negative than -25 cm H2O |
| Tidal Volume (VT) | >5 mL/kg |
| Vital Capacity (VC) | >10 mL/kg |
| Minute Ventilation (MV) | <10 L/min |
| Rapid Shallow Breathing Index (RSBI) | <100-105 breaths/min/L |
| FiO2 needed | ≤0.5 |
| PEEP needed | ≤5-8 cm H2O |
- Morgan and Mikhail's Clinical Anesthesiology 7e, p. 4276-4281
13.3 Rapid Shallow Breathing Index (RSBI)
RSBI is the most widely used and validated weaning predictor:
RSBI = f (breaths/min) / VT (liters)
- RSBI <105 breaths/min/L: most patients can be successfully extubated
- RSBI >120 breaths/min/L: retain mechanical ventilatory support
- Measured during T-piece spontaneous breathing
13.4 Spontaneous Breathing Trial (SBT)
The gold-standard test before extubation:
Eligibility (2024 AARC/ATS criteria):
- FiO2 <50%, PEEP ≤8 cm H2O
- pH >7.32, RR 8-35, HR <130, MAP >60 with low/no vasopressors
- Arousable (RASS > -2), able to cough
Methods:
- T-piece trial - ETT connected to humidified oxygen, no ventilator support
- Low-level CPAP (5 cm H2O)
- Pressure Support (PSV 5-8 cm H2O + PEEP 5 cm H2O) - standard in most ICUs; "automated tube compensation" provides just enough PS to overcome ETT resistance (typically PSV 5 + PEEP 5 cm H2O for size 7.5-8.5 ETT)
SBT failure signs: RR >35, SpO2 <90%, HR increase >20%, BP change >20 mmHg, increasing use of accessory muscles, diaphoresis, agitation
13.5 Weaning Techniques
SIMV weaning: Progressively decrease mandatory rate by 1-2 breaths/min as long as PaCO2 remains acceptable (<45-50 mm Hg) and RR <30/min. Check ABG minimum 15-30 minutes after each change. If pressure support is used concomitantly, reduce to 5-8 cm H2O.
PSV weaning: Decrease pressure support level incrementally (by 2-3 cm H2O steps) while monitoring work of breathing and gas exchange.
T-piece trials: Progressive periods of unsupported breathing, lengthening duration.
13.6 Tracheostomy Timing
For patients expected to require prolonged ventilation, tracheostomy is typically considered around day 7 of mechanical ventilation. Advocates for early tracheostomy cite decreased sedation needs and improved patient comfort; however, data on optimal timing remain debatable.
- Sabiston Textbook of Surgery, p. 3042-3043
13.7 Liberation Guidelines (2024 Updates)
- AARC 2024 Spontaneous Breathing Trial Guideline: Formal SBT with daily readiness assessment using protocolized approach (nurse/respiratory therapist-driven) shortens MV duration and ICU LOS compared to physician-directed weaning alone
- Korean Society of Critical Care Medicine 2024: Liberation protocols driven by nurses/RTs reduce MV duration; daily readiness screening is standard of care
- ATS/ACCP 2017 (still current): Daily SBTs are recommended; protocolized weaning reduces duration of ventilation
14. Extubation Assessment
Extubation follows successful SBT and requires additional evaluation:
| Assessment | Criterion |
|---|
| Level of consciousness | Awake, follows commands |
| Cough strength | Adequate cough for secretion clearance |
| Secretion burden | Manageable amount |
| Cuff-leak test | Positive leak suggests adequate subglottic space (reduces post-extubation stridor risk) |
| Upper airway exam | No anticipated obstruction |
| Oxygenation | SpO2 >90% on FiO2 ≤0.4 with PEEP ≤5 cm H2O |
Cuff-Leak Test: Deflate ETT cuff; if air leaks around the tube during inspiration, the airway is adequately patent. No leak suggests subglottic edema and risk of post-extubation stridor/reintubation.
15. Telemedicine and Patient-Ventilator Assessment
The 2024 AARC CPG specifically addresses the expanding role of telemedicine in ICU ventilator management. Remote monitoring of ventilator parameters, waveforms, and alarms allows ICU specialists to support bedside teams in smaller hospitals. Key domains evaluated remotely include:
- Lung-protective ventilation compliance (VT, Pplat)
- Airway humidification adequacy
- Artificial airway assessment
- SBT readiness screening
The CPG emphasizes that patient-ventilator assessment should remain patient-centric - skilled clinicians integrate ventilator data with bedside clinical examination, not the reverse.
16. Summary Evaluation Framework
A structured approach to evaluating a mechanically ventilated patient:
Step 1 - Clinical Assessment: Mental status, respiratory effort, accessory muscle use, synchrony with ventilator, hemodynamics
Step 2 - Ventilator Parameter Review: Mode, FiO2, PEEP, VT, RR, I:E ratio, flow rates
Step 3 - Waveform Analysis: Scalar and loop analysis for auto-PEEP, air trapping, compliance changes, circuit issues
Step 4 - Pressure Assessment: Peak pressure, plateau pressure, driving pressure targets met?
Step 5 - Gas Exchange: ABG (PaO2, PaCO2, pH, P/F ratio), SpO2, ETCO2
Step 6 - Complication Screening: Signs of VILI, VAP, hemodynamic compromise, auto-PEEP
Step 7 - Liberation Readiness: Daily assessment against weaning criteria; RSBI; SBT initiation if eligible
References (Textbook Sources)
- Goldman-Cecil Medicine (International Edition) - Chapters 90, 91
- Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume Set
- Morgan and Mikhail's Clinical Anesthesiology, 7e - Chapter 58
- Rosen's Emergency Medicine: Concepts and Clinical Practice
- Current Surgical Therapy, 14e - Chapter on Mechanical Ventilation
- Mulholland and Greenfield's Surgery: Scientific Principles and Practice, 7e
- Miller's Anesthesia, 2-Volume Set, 10e - Chapters 33, 79
- Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice
- AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
- AARC Clinical Practice Guideline: Spontaneous Breathing Trials for Liberation from Adult Mechanical Ventilation (2024)
- Korean Society of Critical Care Medicine: Liberation from MV Guidelines (2024) [PMID: 38772682]---
This report covers all major domains of mechanical ventilator evaluation. Here is a quick overview of what was covered:
Report Highlights:
- Definition & Indications - when and why MV is initiated (airway compromise, hypoxemia, hypoventilation, ARDS, intraoperative support)
- Modes - CMV/AC, SIMV, PSV, volume-control, pressure-control, APRV, HFOV with their clinical applications and limitations
- Initial Settings - FiO2, VT (6-8 mL/kg IBW), RR, PEEP targets with rationale
- Monitoring & Evaluation Framework - waveform analysis (scalars and loops), plateau pressure, driving pressure, ABG, auto-PEEP detection
- VILI - four mechanisms: barotrauma, volutrauma, atelectrauma, biotrauma, and their prevention
- Complications - hemodynamic compromise, VAP, oxygen toxicity, respiratory muscle wasting
- Weaning/Liberation - readiness criteria, RSBI (<105 is favorable), SBT methods, SIMV and PSV weaning techniques, tracheostomy timing
- 2024 Guidelines - AARC Patient-Ventilator Assessment CPG: strong recommendation to assess Pplat and VT for lung-protective ventilation
All content sourced from major authoritative textbooks (Goldman-Cecil, Murray & Nadel, Morgan & Mikhail, Miller's Anesthesia, Rosen's Emergency Medicine, Sabiston Surgery) and updated with 2024 clinical practice guidelines.